Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals – Advances Vision 3×3 to extend global clinical and commercial reach – COPENHAGEN, Denmark, Jan. 08, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today announced an equity investment of $12.5 million in VISEN Pharmaceuticals (VISEN) as part of VISEN’s $150 million Series B financing. “Our relationship with VISEN is a key element of our Vision 3×3 stra...
Source: forextv.com